T CELL SCIENCES, INC.

Basic Information

119 FOURTH AVENUE
Needham, MA, 02194

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. PEPTIDE VACCINE TO PREVENT/TREAT ATHEROSCLEROSIS

    Amount: $96,407.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  2. DEVELOPMENT OF A TRANSGENIC RAT ATHEROSCLEROSIS MODEL

    Amount: $677,986.00

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  3. PLASMID BASED VACCINE TO PREVENT/TREAT ATHEROSCLEROSIS

    Amount: $99,999.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  4. DEVELOPMENT OF A TRANSGENIC RAT ATHEROSCLEROSIS MODEL

    Amount: $100,000.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  5. THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO UNDERSTAND THEMOLECULAR BASIS OF T CELL RECOGNITION OF TUMOR ANTIGENS OF LUNG CARCINOMA.

    Amount: $50,000.00

    THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO UNDERSTAND THEMOLECULAR BASIS OF T CELL RECOGNITION OF TUMOR ANTIGENS OF LUNG CARCINOMA. THE SPECIFIC AIMS OF THE PROPOSED STUDY ARE(1) TO CHARACTERIZE TH ...

    SBIR Phase I 1986 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government